Duyuru • Mar 20
Solesence, Inc. to Report Q4, 2025 Results on Mar 31, 2026 Solesence, Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 31, 2026 Duyuru • Oct 30
Solesence, Inc. to Report Q3, 2025 Results on Nov 11, 2025 Solesence, Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 11, 2025 Duyuru • Jul 31
Solesence, Inc., Annual General Meeting, Aug 28, 2025 Solesence, Inc., Annual General Meeting, Aug 28, 2025. Location: companys corporate headquarters, 1319 marquette drive, romeoville, illinois, United States Duyuru • Jul 24
Solesence, Inc. to Report Q2, 2025 Results on Jul 31, 2025 Solesence, Inc. announced that they will report Q2, 2025 results After-Market on Jul 31, 2025 Duyuru • Apr 29
Solesence, Inc. to Report Q1, 2025 Results on May 05, 2025 Solesence, Inc. announced that they will report Q1, 2025 results After-Market on May 05, 2025 Duyuru • Apr 10
Nanophase Technologies Corporation COM Deleted from OTC Equity Nanophase Technologies Corporation COM has been deleted from OTC Equity effective April 08, 2025, due to Market Center Change Listed on NASDAQ. Duyuru • Dec 26
Nanophase Technologies Corporation Approves Directorate Appointments Nanophase Technologies Corporation approved Election of two director nominees. Jess A. Jankowski and Mark E. Miller. Duyuru • Oct 25
Nanophase Technologies Corporation to Report Q3, 2024 Results on Oct 30, 2024 Nanophase Technologies Corporation announced that they will report Q3, 2024 results at 4:00 PM, US Eastern Standard Time on Oct 30, 2024 Duyuru • Aug 07
Nanophase Technologies Corporation Provides Revenue Guidance for the Second Half of 2024 and Earnings Guidance for the Rest of 2024 Nanophase Technologies Corporation provided revenue guidance for the second half of 2024 and earnings guidance for the rest of 2024. With the company's second half revenue expected to exceed first half performance by more than 20%, the company remain poised to continue the strong revenue growth that has been the hallmark of the past five years for the Company. The company now demonstrating margin performance above the company's industry averages enabled by the company's focus on both operational improvements and financial management to lower costs and contain expenses.
The company sharing the company's positive outlook for the rest of 2024. Duyuru • Jul 30
Nanophase Technologies Corporation to Report Q2, 2024 Results on Aug 06, 2024 Nanophase Technologies Corporation announced that they will report Q2, 2024 results at 4:00 PM, US Eastern Standard Time on Aug 06, 2024 Duyuru • Apr 21
Nanophase Technologies Corporation to Report Q1, 2024 Results on Apr 23, 2024 Nanophase Technologies Corporation announced that they will report Q1, 2024 results at 4:00 PM, US Eastern Standard Time on Apr 23, 2024 Duyuru • Apr 11
Nanophase Technologies Corporation Announces Successful Litigation Settlement with BASF Nanophase Technologies Corporation announced that it has agreed to a successful and amicable resolution of all ongoing litigation with BASF. The parties have executed a Settlement Agreement, an amendment to their existing supply contract, and a joint stipulation to dismiss the case with prejudice to be filed in the Superior Court of New Jersey within the next five business days. Duyuru • Mar 06
Nanophase Technologies Corporation to Report Fiscal Year 2023 Results on Mar 20, 2024 Nanophase Technologies Corporation announced that they will report fiscal year 2023 results on Mar 20, 2024 Duyuru • Nov 23
Nanophase Technologies Corporation has filed a Follow-on Equity Offering in the amount of $2 million. Nanophase Technologies Corporation has filed a Follow-on Equity Offering in the amount of $2 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 5,000,000
Price\Range: $0.4
Transaction Features: Rights Offering Duyuru • Nov 08
Nanophase Technologies Corporation to Report Q3, 2023 Results on Nov 13, 2023 Nanophase Technologies Corporation announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 13, 2023 Duyuru • Nov 07
Nanophase Technologies Corporation, Annual General Meeting, Nov 15, 2023 Nanophase Technologies Corporation, Annual General Meeting, Nov 15, 2023, at 08:30 Central Standard Time. Location: headquarters, 1319 Marquette Drive, Romeoville, Illinois, Illinois United States Agenda: To ratify the appointment by the Company’s Audit and Finance Committee of RSM US LLP as the independent auditors of the Company’s financial statements for the year ending December 31, 2023; to transact such other business as may properly come before the meeting or any adjournments ; and to consider other matters if any. Duyuru • Jul 29
Nanophase Technologies Corporation to Report Q2, 2023 Results on Aug 02, 2023 Nanophase Technologies Corporation announced that they will report Q2, 2023 results at 4:00 PM, US Eastern Standard Time on Aug 02, 2023 Duyuru • Jul 23
Mark E. Miller Joins Nanophase Technologies Corporation's Board of Directors, Effective as of July 19, 2023 Nanophase Technologies Corporation announced the appointment of Mark E. Miller to its Board of Directors. Miller, a veteran of many of the industries and markets served by Nanophase, and its wholly owned subsidiary Solésence LLC, brings 36 years of leadership and commercial experience in specialty materials and chemicals in the Personal Care, Pharma, CASE, and Metals markets. Miller was most recently the President & COO of Nagase Specialty Materials NA LLC (Itasca, IL) before departing in April 2023. Miller’s appointment as an independent director is effective as of July 19, 2023. Duyuru • May 10
Nanophase Technologies Corporation to Report Q1, 2023 Results on May 11, 2023 Nanophase Technologies Corporation announced that they will report Q1, 2023 results at 4:00 PM, US Eastern Standard Time on May 11, 2023 Duyuru • Dec 03
Nanophase Technologies Corporation, Annual General Meeting, Dec 14, 2022 Nanophase Technologies Corporation, Annual General Meeting, Dec 14, 2022, at 08:30 Central Standard Time. Location: 1319 Marquette Drive Romeoville United States Agenda: To elect two Class I directors to the Company’s Board of Directors; to consider the approval of the advisory vote on the compensation paid to our named executive officers; to ratify the appointment by the Company’s Audit and Finance Committee of RSM US LLP as the independent auditors of the Company’s financial statements for the year ending December 31, 2022; and to transact such other business as may properly come before the meeting or any adjournments thereof. Duyuru • Nov 02
Nanophase Technologies Corporation to Report Q3, 2022 Results on Nov 08, 2022 Nanophase Technologies Corporation announced that they will report Q3, 2022 results at 4:00 PM, US Eastern Standard Time on Nov 08, 2022 Duyuru • Sep 08
BASF Files a Complaint against Nanophase Nanophase Technologies Corporation on September 7, 2022 filed an 8-K referencing that BASF, one of its customers, filed a complaint against Nanophase in the Superior Court of New Jersey. Among other things, the complaint alleges that Nanophase breached the exclusivity provisions of a supply agreement through the sale of zinc oxide based products through its Solésence subsidiary. In response to BASF’s action, Nanophase has in turn filed a Complaint for Declaratory Judgment in the Circuit Court of Cook County regarding the exclusivity terms within the agreement. While management is disappointed that it has come to this point after two decades of supply to BASF and over a half-decade of operating the Solésence business, the Company is fully confident in its position and will take the necessary steps to defend it. Duyuru • Aug 17
Nanophase Technologies Corporation announced delayed 10-Q filing On 08/16/2022, Nanophase Technologies Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Duyuru • Aug 13
Nanophase Technologies Corporation to Report Q2, 2022 Results on Aug 17, 2022 Nanophase Technologies Corporation announced that they will report Q2, 2022 results at 4:00 PM, US Eastern Standard Time on Aug 17, 2022 Duyuru • May 05
Nanophase Technologies Corporation to Report Q1, 2022 Results on May 11, 2022 Nanophase Technologies Corporation announced that they will report Q1, 2022 results After-Market on May 11, 2022 Duyuru • Mar 31
Nanophase Technologies Corporation to Report Q4, 2021 Results on Mar 31, 2022 Nanophase Technologies Corporation announced that they will report Q4, 2021 results After-Market on Mar 31, 2022 Duyuru • Mar 03
Solésence Beauty Science Expands to Australian Market as Nanophase Technologies Receives TGA GMP Site Clearance Solésence Beauty Science announced that it has been issued TGA GMP site clearance for the full finished product manufacture of creams, lotions, sprays, sticks and all topical sunscreen forms. The site clearance has been granted to Nanophase Technologies, of which Solésence is a wholly owned subsidiary. An innovation-driven beauty science company, Solésence finished goods offer brands patented formulas that leverage an ever-expanding suite of environmental protection technologies within their own Active Stress Defense™ platform. These technologies, which target aggressors such as UV, pollution and HEV (blue) light, are only available through the finished goods that they develop and manufacture. TGA GMP site clearance signals the possibility of expansion into Australian markets. Duyuru • Nov 14
Nanophase Technologies Corporation, Annual General Meeting, Dec 09, 2020 Nanophase Technologies Corporation, Annual General Meeting, Dec 09, 2020, at 08:30 Central Standard Time. Location: 1319 Marquette Drive Romeoville Illinois United States Agenda: To elect one Class II director to the Company’s Board of Directors; to ratify the appointment by the Company’s Audit and Finance Committee of RSM US LLP as the independent auditors of the Company’s financial statements for the year ending December 31, 2020; and to transact such other business as may properly come before the meeting or any adjournments thereof. Duyuru • Nov 06
Nanophase Technologies Corporation Appoints Laura M. Beres to the Audit and Finance Committee, Compensation Committee, and Nominating and Corporate Governance Committee Nanophase Technologies Corporation Laura M. Beres has been appointed to the Audit and Finance Committee, Compensation Committee, and Nominating and Corporate Governance Committee. Duyuru • Oct 30
Nanophase Technologies Corporation Appoints Laura M. Beres to its Board of Directors Nanophase Technologies Corporation announced the appointment of Laura M. Beres to its Board of Directors. Beres’ appointment as an independent director is effective as of October 28, 2020. Beres is director of corporate strategy at Ulta Beauty. Beres leads Conscious Beauty at Ulta Beauty, a holistic program that offers enhanced transparency and choice around clean ingredients and sustainability. 
